Copyright
©The Author(s) 2024.
World J Clin Oncol. Oct 24, 2024; 15(10): 1293-1308
Published online Oct 24, 2024. doi: 10.5306/wjco.v15.i10.1293
Published online Oct 24, 2024. doi: 10.5306/wjco.v15.i10.1293
Group | Number | Weight/g | Tumor volume/mm3 | Tumor weight/g | Anti-tumor rate (%) |
Control | 3 | 18.83 ± 0.15 | |||
Model | 3 | 15.133 ± 0.40b | 1641.48 ± 499.84 | 1.25 ± 0.13 | |
Capecitabine | 3 | 17.633 ± 0.06b | 616.98 ± 156.00a | 0.56 ± 0.15b | 62.41 |
BXD-L | 3 | 16.833 ± 0.06b | 726.37 ± 168.48a | 0.77 ± 0.08b | 55.75 |
BXD-M | 3 | 17.673 ± 0.15b | 541.85 ± 95.72a | 0.51 ± 0.09b | 66.99 |
BXD-H | 3 | 17 ± 0.1b | 682.00 ± 281.61a | 0.55 ± 0.13b | 58.48 |
- Citation: Zu GX, Sun KY, Liu XJ, Tang JQ, Huang HL, Han T. Banxia xiexin decoction prevents the development of gastric cancer. World J Clin Oncol 2024; 15(10): 1293-1308
- URL: https://www.wjgnet.com/2218-4333/full/v15/i10/1293.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i10.1293